State of Wisconsin Investment Board’s PMV Pharmaceuticals PMVP Stock Holding History

State of Wisconsin Investment Board’s Portfolio PMVP Stock Details PMVP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-80,600	Closed	-$495K	–	2529
2023 Q3	$495K	Sell	80,600 -27,500	-25%	-$189K	﹤0.01%	1771
2023 Q2	$677K	Buy	108,100 +45,095	+72%	+$236K	﹤0.01%	1660
2023 Q1	$301K	Buy	63,005 +43,365	+221%	+$305K	﹤0.01%	2097
2022 Q4	$171K	Sell	19,640 -1,283	-6%	-$13.7K	﹤0.01%	2272
2022 Q3	$249K	Buy	20,923 +6,598	+46%	+$95.3K	﹤0.01%	2314
2022 Q2	$204K	Sell	14,325 -19,575	-58%	-$285K	﹤0.01%	2477
2022 Q1	$706K	Hold	33,900	–	–	﹤0.01%	1720
2021 Q4	$783K	Hold	33,900	–	–	﹤0.01%	1528
2021 Q3	$1.01M	Hold	33,900	–	–	﹤0.01%	1447
2021 Q2	$1.16M	Buy	33,900 +15,500	+84%	+$518K	﹤0.01%	1407
2021 Q1	$605K	Buy	+18,400	New	+$725K	﹤0.01%	1526

Other funds holding PMVP

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State of Wisconsin Investment Board's PMVP Position: Q4 2023 in Review

State of Wisconsin Investment Board sold out of PMV Pharmaceuticals (PMVP) in Q4 2023, closing a stake of 80,600 shares — an estimated $495K sold.

State of Wisconsin Investment Board first reported a position in PMVP in Q1 2021 and held it in 11 quarters. The position peaked at $1.16M in Q2 2021. 98 funds tracked by Wall St. Rank hold PMVP as of Q4 2023.

State of Wisconsin Investment Board reported no remaining PMV Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
State of Wisconsin Investment Board sold 80,600 PMV Pharmaceuticals shares in Q4 2023, an estimated $495K.
State of Wisconsin Investment Board first reported a position in PMV Pharmaceuticals in Q1 2021 and held it in 11 quarters.
State of Wisconsin Investment Board's PMV Pharmaceuticals position peaked at $1.16M in Q2 2021.
98 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2023, filed 12 Feb 2024.